About Us

We are Committed to being a Collaborative Platform for Innovative Biotech Companies from around the World.

Viva BioInnovator ("VBI") is the investment division of Viva Biotech Holdings (1873.HK). We are solely dedicated to the identification and success of early-stage, biotech start-ups for Viva’s incubation, equity-for-service, and investment platforms. Our commitment is to operate a collaborative platform for innovative biotech companies from around the world, and for anyone aiming to develop an idea with transformative or strong potential.


We invest in some of the most innovative founders to build a unique portfolio covering a wide range of indications and drug types.

  • ABM Therapeutics, Inc.
  • AceLink Therapeutics
  • AcuraStem
  • AmacaThera, Inc.
  • Anji Pharmaceuticals Inc.
  • Arthrosi Therapeutics, Inc
  • Blue Oak
  • Bonti, INC.
  • Bright Angel Therapeutics
  • Calira Therapeutics LLC
  • Dogma Therapeutics, Inc.
  • DTx Pharma
  • Elgia
  • Epican Technology Limited
  • Flash Therapeutics, LLC
  • Focus-X
  • Forkhead BioTherapeutics, LLC
  • Jiaxing Youbo Biotechnology Co., Ltd.
  • Livati
  • Mediar Therapeutics, Inc.
  • MorphoGene
  • Ophidion
  • Panacea Bio
  • Path Therapeutics
  • Phenomic AI
  • Proviva
  • QurAlis Corporation
  • QurClear
  • QureBio
  • Regenacy
  • Reglagene
  • Riparian Pharmaceuticals,Inc.
  • Saverna Therapeutics
  • Seraxis
  • Sisu Pharma
  • Tabomedex Biosciences, Inc.
  • Technoderma
  • Totient Inc.
  • Trio Bio,LCC
  • Triumvira
  • Twin Lanterns Bio, LLC
  • United InnoMed
  • VersaPeutics, Inc.
  • Vincere
  • VivaVision Biopharma
  • Wei Qing biology
  • XLement
  • Zing Bio,LLC


Read the most up to date information about us and our partners.